Dartmouth's Gilbert Welch and UW's Wylie Burke teamed up to write an opinion piece in today's Newsday about the merits of consumer genomics. Though it sounds promising, they say the tests don't provide definitive information, especially about treatment. "We need more research, not pricey genomic scans. Until then, save your money, and spare your health," they write.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.